Skip to content

Drug interactions

Crizotinib + Temsirolimus

Severity: Moderate

Crizotinib and Temsirolimus: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Crizotinib is a moderate CYP3A inhibitor and may raise exposure to temsirolimus and its active metabolite sirolimus. Higher exposure may increase mTOR-related adverse effects such as mucositis, hyperglycemia, hyperlipidemia, cytopenias and pneumonitis.

What this interaction means in plain words

Crizotinib and Temsirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Crizotinib belongs to Oncology; Temsirolimus belongs to Oncology.

Evidence level: Low

Why it happens

Crizotinib inhibits CYP3A4-mediated metabolism of temsirolimus and sirolimus.

What to do

Monitor for temsirolimus toxicity such as mucositis, cytopenias, glucose and lipid abnormalities, and pulmonary symptoms. Consider dose reduction of temsirolimus if adverse effects emerge.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Crizotinib and Temsirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Crizotinib with Temsirolimus?

MediHelp rates the interaction as moderate. Crizotinib and Temsirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Crizotinib is a moderate CYP3A inhibitor and may raise exposure to temsirolimus and its active metabolite sirolimus. Higher exposure may increase mTOR-related adverse effects such as mucositis, hyperglycemia, hyperlipidemia, cytopenias and pneumonitis.

How serious is the interaction between Crizotinib and Temsirolimus?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for temsirolimus toxicity such as mucositis, cytopenias, glucose and lipid abnormalities, and pulmonary symptoms. Consider dose reduction of temsirolimus if adverse effects emerge.

What other medicines interact with Temsirolimus?

MediHelp also lists interactions of Temsirolimus with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine live. The full list is on the Temsirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in